Halozyme Therapeutics Inc (HALO)
45.70
-0.06
(-0.13%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.12
(+0.26%)
After-Hours: 20:00
Halozyme Therapeutics Total Liabilities (Quarterly): 1.665B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.665B |
| June 30, 2024 | 1.680B |
| March 31, 2024 | 1.664B |
| December 31, 2023 | 1.649B |
| September 30, 2023 | 1.643B |
| June 30, 2023 | 1.659B |
| March 31, 2023 | 1.634B |
| December 31, 2022 | 1.672B |
| September 30, 2022 | 1.768B |
| June 30, 2022 | 1.488B |
| March 31, 2022 | 901.99M |
| December 31, 2021 | 907.48M |
| September 30, 2021 | 903.75M |
| June 30, 2021 | 906.12M |
| March 31, 2021 | 898.99M |
| December 31, 2020 | 428.88M |
| September 30, 2020 | 425.04M |
| June 30, 2020 | 421.42M |
| March 31, 2020 | 434.31M |
| December 31, 2019 | 474.11M |
| September 30, 2019 | 125.00M |
| June 30, 2019 | 157.78M |
| March 31, 2019 | 169.06M |
| December 31, 2018 | 191.36M |
| September 30, 2018 | 204.77M |
| Date | Value |
|---|---|
| June 30, 2018 | 219.83M |
| March 31, 2018 | 230.40M |
| December 31, 2017 | 311.58M |
| September 30, 2017 | 284.76M |
| June 30, 2017 | 286.62M |
| March 31, 2017 | 285.27M |
| December 31, 2016 | 294.00M |
| September 30, 2016 | 294.49M |
| June 30, 2016 | 286.21M |
| March 31, 2016 | 279.62M |
| December 31, 2015 | 138.79M |
| September 30, 2015 | 126.94M |
| June 30, 2015 | 123.82M |
| March 31, 2015 | 121.58M |
| December 31, 2014 | 124.62M |
| September 30, 2014 | 124.69M |
| June 30, 2014 | 126.75M |
| March 31, 2014 | 130.94M |
| December 31, 2013 | 121.78M |
| September 30, 2013 | 113.63M |
| June 30, 2013 | 96.24M |
| March 31, 2013 | 85.19M |
| December 31, 2012 | 85.87M |
| September 30, 2012 | 56.79M |
| June 30, 2012 | 52.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
421.42M
Minimum
Jun 2020
1.768B
Maximum
Sep 2022
1.161B
Average
1.198B
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 34.33B |
| Novavax Inc | 2.239B |
| Insulet Corp | 1.907B |
| BioLife Solutions Inc | 56.19M |
| TransMedics Group Inc | 575.65M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.118B |
| Shareholders Equity (Quarterly) | 452.70M |
| Debt to Equity Ratio | 3.323 |
| Current Ratio | 10.36 |
| Net Debt Paydown Yield | -0.02% |